Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system, including gallstones, biliary strictures, and bile duct tumors. It is a minimally invasive procedure which involves the insertion of a needle into the liver to access the bile ducts for visualization. PTC can provide valuable information about the anatomy and function of the biliary system, which is essential for accurate diagnosis and treatment. In this article, we will discuss the basics of PTC, its indications, risks, and benefits.
Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system. It involves the insertion of a needle through the skin into the liver to access the bile ducts for visualization. PTC is often used to diagnose and treat gallstones, biliary strictures, and bile duct tumors. The procedure is performed under local anesthesia and usually takes about 30 minutes to complete. During the procedure, a contrast material is injected into the bile ducts. This contrast material allows the doctor to see the bile ducts on an X-ray.
PTC is indicated in a number of situations. It is often used to diagnose and treat biliary strictures, which are narrowings of the bile ducts. It can also be used to diagnose and treat gallstones, which can cause pain and other symptoms. PTC can also be used to diagnose and treat bile duct tumors.
PTC is generally a safe procedure, but there are some risks associated with it. The most common risks include infection, bleeding, and damage to the bile ducts. There is also a risk of allergic reaction to the contrast material used during the procedure.
PTC can provide valuable information about the anatomy and function of the biliary system. This information is essential for accurate diagnosis and treatment. PTC can also be used to treat certain conditions, such as biliary strictures and gallstones. In addition, PTC is a minimally invasive procedure, which means it is less risky than more invasive procedures.
Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system. It is a minimally invasive procedure which involves the insertion of a needle into the liver to access the bile ducts for visualization. PTC can provide valuable information about the anatomy and function of the biliary system, which is essential for accurate diagnosis and treatment. In addition, PTC can be used to treat certain conditions, such as biliary strictures and gallstones. Although there are some risks associated with PTC, it is generally a safe procedure with many benefits.
1.
Vaccine shows promise for pancreatic cancer, study finds
2.
After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.
3.
FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.
4.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
5.
Tumor characteristics found to differ for melanomas in children, teens and young adults
1.
The Ins and Outs of Glossectomy: What You Need to Know
2.
The Pros and Cons of Steroid Therapy for ITP
3.
Comprehensive Applications in Hematology for Better Care
4.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
5.
Physical Performance Recovery in Patients With Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Navigating the Complexities of Ph Negative ALL - Part V
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
Efficient Management of First line ALK-rearranged NSCLC - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation